Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
February 11-12, 2015 - The Waldorf Astoria, New York City, US
February 9-10, 2015 - The Waldorf Astoria, New York City, US
January 12-15, 2015 - the Westin St. Francis, San Francisco, US